Continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers before non-cardiac surgery is linked to a reduced risk of postoperative mortality and functional decline, ...
Weight-loss experts explain why combining GLP-1 medications with bariatric surgery may be the most effective approach to treating obesity in 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback